Khakimov A G, Semeikin O V, Merkulova I N, Frolova E P, Mazaev A V
Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR. 1989;12(1):31-6.
Allapinin after i.v. bolus infusion in a dose of 30 mg is relatively quickly eliminated from blood (in patients without congestive heart failure half-elimination period is 2.4 +/- 0.5 h and clearance is 79.0 +/- 8.9 l/h) which makes a good reason for its intravenous infusion according to the scheme "load dose + drop infusion". Marked heart failure in patients with acute myocardial infarction compared to patients without heart failure results in reduced elimination rate, decreased clearance, significantly increased plasma allapinin concentration which should be taken in account when choosing the regime of drug infusion. The elimination of allapinin is mainly metabolic and not renal (only about 17% of the drug is excreted with urine).
静脉推注30毫克剂量的阿拉平宁后,其从血液中消除相对较快(在无充血性心力衰竭的患者中,半衰期为2.4±0.5小时,清除率为79.0±8.9升/小时),这为按照“负荷剂量+滴注”方案进行静脉输注提供了充分理由。与无心力衰竭的患者相比,急性心肌梗死患者出现明显心力衰竭会导致消除率降低、清除率下降、血浆阿拉平宁浓度显著升高,在选择药物输注方案时应考虑到这一点。阿拉平宁的消除主要是代谢性的,而非肾性(只有约17%的药物通过尿液排泄)。